Posts in tag

statins


The High Court has dismissed the ACCC’s application for special leave to appeal the Full Federal Court decision in a case against Pfizer In early 2012, Pfizer offered significant discounts …

It’s been a busy week in the pharmacy sector, with new information on drug trends, a number of health awareness days and another shot in the turf war There was …

A review of the benefits of statins has found a lack of convincing evidence for the drugs’ use in helping prevent conditions such as cancer and Alzheimer’s disease While some …

Debbie Rigby rounds up the latest in research news  A Pharmacist’s Review of Asthma Asthma is a lifelong respiratory disease that calls for proper pharmacotherapy, patient counselling, and an action …

PDL has highlighted the importance of taking patient concerns and questions seriously, after a dispensing error contributed to a patient’s death In a recent coronial inquest, it was found that …

The ACCC is seeking special leave to appeal the dismissal of its allegations against Pfizer Australia The Australian Competition and Consumer Commission is seeking leave from the High Court to …

Debbie Rigby rounds up the latest in research news Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder A systematic review …

The composite packs in four different dosage strengths are predicted to be in shortage in Australia until end of January Atozet tablets, used for hypercholesterolaemia, are currently experiencing a shortage. …

Expensive medicines used to treat hepatitis C have cost the government more than any other drugs over the past year New figures based on PBS and RPBS scripts for the …

Debbie Rigby rounds up the latest in research news Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults A two year substudy of a trial with …

Debbie Rigby takes a look at the latest in research news Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy In this population-based …

Debbie Rigby takes a look at the latest in research news Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL …